articleNew England Journal of MedicineDec 24, 2003Closed access

Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

Hôpital Purpan · Hôpital Claude Huriez · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

We conducted a randomized trial of the treatment of multiple myeloma with high-dose chemotherapy followed by either one or two successive autologous stem-cell transplantations.

Methods

At the time of diagnosis, 399 previously untreated patients under the age of 60 years were randomly assigned to receive a single or double transplant.

Citation impact

974
total citations
FWCI
26.88
Percentile
100%
References
16
Citations per year

Authors

14

Topics & keywords

Keywords
  • Medicine
  • Multiple myeloma
  • Transplantation
  • Surgery
  • Chemotherapy
  • Melphalan
  • Autologous stem-cell transplantation
  • Internal medicine
No related works found for this paper.